Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and calculations
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Prurigo nodularis treatment industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Distribution channel trends
2.1.4 Regional trends
Chapter 3 Prurigo Nodularis Treatment Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.2.1 Vendor matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Pricing analysis 2018 – 2032
3.3.1 Pricing analysis, by region
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific
3.3.1.4 Latin America
3.3.1.5 Middle East & Africa
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Growing pharmaceutical and biotechnology industry
3.4.1.2 Rising focus on orphan drug development
3.4.1.3 Increasing prevalence of prurigo nodularis treatment market in developing nations
3.4.2 Industry pitfalls & challenges
3.4.2.1 Limited approved targeted therapy/drug in the market
3.5 Growth potential analysis
3.5.1 By product
3.5.2 By distribution channel
3.6 COVID- 19 impact analysis
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Technology landscape
3.9 Industry eco-system
3.9.1 Current trends in the industry
3.9.2 Start-up scenario
3.10 Porter's analysis
3.10.1 Bargaining power of suppliers
3.10.2 Bargaining power of buyers
3.10.3 Threat of new entrants
3.10.4 Threat of substitutes
3.10.5 Industry rivalry
3.11 PESTEL analysis
3.11.1 Political
3.11.2 Economical
3.11.3 Social
3.11.4 Technological
3.11.5 Environmental
3.11.6 Legal
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company market share, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Prurigo Nodularis Treatment Market, By Product
5.1 Key device trends
5.2 Antihistamines
5.3 Capsaicin cream
5.4 Corticosteroids
5.5 Emollients
5.6 Others
Chapter 6 Prurigo Nodularis Treatment Market, By Distribution Channel
6.1 Key distribution channel trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies
Chapter 7 Prurigo Nodularis Treatment Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
Chapter 8 Company Profiles
8.1 Johnson & Johnson Services Inc.
8.2 Pfizer Inc.
8.3 Merck & Co. Inc.
8.4 Sanofi
8.5 Teva Pharmaceuticals
8.6 GlaxoSmithKline plc
8.7 Takeda Pharmaceuticals
8.8 Bayer AG
8.9 Galderma
8.10 Trevi Therapeutics, Inc
